Pfizer begins stage 2 and 3 trials of COVID-19 antiviral treatment on children

Pfizer on Wednesday announced it has begun the Phase 2 and 3 stages of its study into the use of its antiviral COVID-19 treatment in young children.

Related Keywords

United States ,Mikael Dolsten ,Ridgeback Molnupiravir ,Pfizer ,Drug Administration ,Covid 19 Drug Development ,Covid 19 ,Nirmatrelvir Ritonavir ,Paxlovid ,Joe Biden , ,